Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Food Funct ; 9(7): 3640-3656, 2018 Jul 17.
Article in English | MEDLINE | ID: mdl-29923573

ABSTRACT

High doses of ß-phenylethyl isothiocyanate (PEITC), a phytochemical in cruciferous vegetables, are not feasible for consumption due to a strong mouth-tingling effect. This study investigated the anti-cancer effect of PEITC at sensory acceptable doses. In vitro, PEITC was selectively toxic to oral cancer cells (CAL-27, FaDu, SCC4, SCC 9, SCC15, SCC25 and TU138), compared to oral keratinocytes (OKF6/TERT2 and NOK/Si). In vivo, 5 and 10 mg kg-1 PEITC, equivalent to human organoleptically acceptable doses, retarded tumor growth and prolonged the survival of mice bearing p53-mutated oral cancer cells - TU138 xenograft. Mechanistically, PEITC induced ROS accumulation, nuclear translocation of p53 and p21 and G1/S cell cycle arrest in vitro; increased p53 and 8-oxo-dG levels; and decreased Ki-67 intense/mild staining ratios without TUNEL changes in vivo. These findings suggested that the sensory acceptable doses of PEITC selectively induced ROS-mediated cell cycle arrest leading to delayed tumor progression and extended survival. PEITC could be a functional ingredient for oral cancer prevention.


Subject(s)
Anticarcinogenic Agents/administration & dosage , Cell Cycle Checkpoints/drug effects , Isothiocyanates/administration & dosage , Mouth Neoplasms/drug therapy , Mouth Neoplasms/physiopathology , Tumor Suppressor Protein p53/genetics , Animals , Anticarcinogenic Agents/analysis , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Humans , Isothiocyanates/analysis , Male , Mice , Mice, Nude , Mouth Neoplasms/genetics , Mouth Neoplasms/metabolism , Taste , Tumor Suppressor Protein p53/metabolism
2.
Mol Cell ; 54(6): 960-974, 2014 Jun 19.
Article in English | MEDLINE | ID: mdl-24857548

ABSTRACT

Many mutant p53 proteins (mutp53s) exert oncogenic gain-of-function (GOF) properties, but the mechanisms mediating these functions remain poorly defined. We show here that GOF mutp53s inhibit AMP-activated protein kinase (AMPK) signaling in head and neck cancer cells. Conversely, downregulation of GOF mutp53s enhances AMPK activation under energy stress, decreasing the activity of the anabolic factors acetyl-CoA carboxylase and ribosomal protein S6 and inhibiting aerobic glycolytic potential and invasive cell growth. Under conditions of energy stress, GOF mutp53s, but not wild-type p53, preferentially bind to the AMPKα subunit and inhibit AMPK activation. Given the importance of AMPK as an energy sensor and tumor suppressor that inhibits anabolic metabolism, our findings reveal that direct inhibition of AMPK activation is an important mechanism through which mutp53s can gain oncogenic function.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Carcinoma, Squamous Cell/genetics , Energy Metabolism/genetics , Head and Neck Neoplasms/genetics , Tumor Suppressor Protein p53/metabolism , AMP-Activated Protein Kinases/antagonists & inhibitors , Acetyl-CoA Carboxylase/metabolism , Animals , Antimetabolites, Antineoplastic/pharmacology , Cell Movement/genetics , Cell Proliferation , Enzyme Activation/genetics , Fluorouracil/pharmacology , Humans , Mice , Mice, Nude , Neoplasm Invasiveness/genetics , Neoplasm Transplantation , Protein Binding/genetics , RNA Interference , RNA, Small Interfering , Ribosomal Protein S6/metabolism , Signal Transduction/genetics , Spheroids, Cellular/cytology , Squamous Cell Carcinoma of Head and Neck , Transplantation, Heterologous , Tumor Cells, Cultured , Tumor Suppressor Protein p53/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...